Form 4 Filing by O'Day Daniel Patrick for Gilead Sciences, Inc.

Daniel Patrick O'Day, Chairman & CEO of Gilead Sciences, Inc. (GILD), reported the sale of 6,950 shares of Common Stock on April 28, 2026, at an average price of $128.79 per share. This transaction was conducted under a Rule 10b5-1 trading plan. Following this sale, O'Day's direct ownership decreased to 635,617 shares. Additionally, a separate sale of 3,050 shares of Common Stock occurred on the same date, with prices ranging from $129.42 to $130.47. This resulted in a further decrease in his direct holdings to 632,567 shares. The sales were executed under a pre-arranged trading plan, indicating a planned divestiture of shares.